Calidi Biotherapeutics, Inc.
CLDI · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $8 | $15 | $9 |
| - Cash | $10 | $5 | $11 | $10 |
| + Debt | $3 | $4 | $5 | $7 |
| Enterprise Value | $0 | $7 | $9 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$6 | -$5 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.21 | -1.99 | -2.21 | -3.22 |
| % Growth | -11.1% | 10% | 31.4% | – |
| Operating Cash Flow | -$4 | -$5 | -$7 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$5 | -$7 | -$5 |